Canada markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.66+0.29 (+3.09%)
At close: 4:00PM EST
Currency in USD

Valuation Measures

Market Cap (intraday) 51.64B
Enterprise Value 31.37B
Trailing P/E N/A
Forward P/E 1-16.37
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)775.54
Price/Book (mrq)5.00
Enterprise Value/Revenue 3651.13
Enterprise Value/EBITDA 6-11.51

Trading Information

Stock Price History

Beta (5Y Monthly) 1.08
52-Week Change 3171.35%
S&P500 52-Week Change 313.47%
52 Week High 333.79
52 Week Low 33.14
50-Day Moving Average 310.39
200-Day Moving Average 313.84

Share Statistics

Avg Vol (3 month) 310.64M
Avg Vol (10 day) 38.76M
Shares Outstanding 5169.41M
Float 166.04M
% Held by Insiders 12.17%
% Held by Institutions 136.49%
Shares Short (Dec. 30, 2020) 456.14M
Short Ratio (Dec. 30, 2020) 44.77
Short % of Float (Dec. 30, 2020) 433.82%
Short % of Shares Outstanding (Dec. 30, 2020) 433.14%
Shares Short (prior month Nov. 29, 2020) 455.37M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jun. 05, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-5,841.53%

Management Effectiveness

Return on Assets (ttm)-26.14%
Return on Equity (ttm)-100.68%

Income Statement

Revenue (ttm)2.11M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-72.80%
Gross Profit (ttm)-82.01M
EBITDA -119.41M
Net Income Avi to Common (ttm)-179.73M
Diluted EPS (ttm)-1.32
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)337.24M
Total Cash Per Share (mrq)1.99
Total Debt (mrq)74.62M
Total Debt/Equity (mrq)23.03
Current Ratio (mrq)9.14
Book Value Per Share (mrq)1.93

Cash Flow Statement

Operating Cash Flow (ttm)-140.5M
Levered Free Cash Flow (ttm)-78.88M